Half-year report · HY

Period2025-07-01 → 2025-12-31
Filed2026-02-13
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 39
MetricValuePeriodScopeSource row
Operating income−¥600m2025-07-01 → 2025-12-31StandaloneOperating income
Operating income−¥469m2024-07-01 → 2024-12-31StandaloneOperating income
Ordinary income−¥568m2025-07-01 → 2025-12-31StandaloneOrdinary income
Ordinary income−¥1.2bn2024-07-01 → 2025-06-30StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥480m2024-07-01 → 2024-12-31StandaloneOrdinary income
Profit before tax−¥568m2025-07-01 → 2025-12-31StandaloneIncome before income taxes
Profit before tax−¥480m2024-07-01 → 2024-12-31StandaloneIncome before income taxes
Net income−¥569m2025-07-01 → 2025-12-31StandaloneProfit loss
Net income−¥1.2bn2024-07-01 → 2025-06-30StandaloneNet income loss (5-year summary)
Net income−¥480m2024-07-01 → 2024-12-31StandaloneProfit loss
Total assets¥2.5bnat 2025-12-31StandaloneAssets
Total assets¥3.1bnat 2025-06-30StandaloneAssets
Total assets¥3.1bnat 2024-12-31StandaloneTotal assets (5-year summary)
Total liabilities¥96mat 2025-12-31StandaloneLiabilities
Total liabilities¥107mat 2025-06-30StandaloneLiabilities
Net assets / equity¥2.4bnat 2025-12-31StandaloneNet assets
Net assets / equity¥2.9bnat 2025-06-30StandaloneNet assets
Net assets / equity¥3.0bnat 2024-12-31StandaloneNet assets (5-year summary)
Cash and deposits¥2.2bnat 2025-12-31StandaloneCash and deposits
Cash and deposits¥2.8bnat 2025-06-30StandaloneCash and deposits
Cash & equivalents¥2.2bnat 2025-12-31StandaloneCash and cash equivalents
Cash & equivalents¥2.8bnat 2025-06-30StandaloneCash and cash equivalents
Cash & equivalents¥2.9bnat 2024-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.9bnat 2024-06-30vStandaloneCash and cash equivalents
Operating cash flow−¥653m2025-07-01 → 2025-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥771m2024-07-01 → 2025-06-30StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥171m2024-07-01 → 2024-12-31StandaloneNet cash provided by used in operating activities
Investing cash flow¥122,0002024-07-01 → 2025-06-30StandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥1.7bn2024-07-01 → 2025-06-30StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.2bn2024-07-01 → 2024-12-31StandaloneNet cash provided by used in financing activities
EPS (basic)¥-28.872025-07-01 → 2025-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-61.142024-07-01 → 2025-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-25.772024-07-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
Equity ratio94.7%at 2025-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio95.4%at 2025-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio95.3%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Shares issued19,713,000at 2025-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued19,713,000at 2025-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued19,113,000at 2024-12-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 309
ItemContextValueUnit
Notes when there is significant changes in amounts of equity (text)Prior1InterimDuration_NonConsolidatedMemberText · Plus
Notes regarding dividend (text)InterimDuration_NonConsolidatedMemberText · Plus
Notes when there is significant changes in amounts of equity (text)InterimDuration_NonConsolidatedMemberText · Plus
Notes segment information etc type1 semi annual financial statements (text)InterimDurationText · Plus
Description of fact that companys business comprises single segmentInterimDuration_NonConsolidatedMember
Original text (Japanese)当社は、医薬品事業の単一セグメントであるため、記載を省略しています。
Notes per share information semi annual financial statements (text)InterimDurationText · Plus
Notes significant events after reporting period semi annual financial statements (text)InterimDurationText · Plus
Other information financial statements etc (text)InterimDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2025-06-30pass
balance sheet identitynon_consolidated 2025-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2025-06-30pass
statement vs summary · net assetsnon_consolidated 2025-12-31pass
statement vs summary · operating cash flownon_consolidated 2024-07-01/2024-12-31pass
statement vs summary · operating cash flownon_consolidated 2025-07-01/2025-12-31pass
statement vs summary · total assetsnon_consolidated 2025-06-30pass
statement vs summary · total assetsnon_consolidated 2025-12-31pass